Evaluation of drug-drug interactions between hepatitis C antiviral agents ombitasvir, paritaprevir/ritonavir, and dasabuvir and HIV-1 protease inhibitors
Evaluation of drug-drug interactions between hepatitis C antiviral agents ombitasvir, paritaprevir/ritonavir, and dasabuvir and HIV-1 protease inhibitors. Clin Infect Dis. 2016;62(8):972-979. .
Publication Type:
Journal ArticleSource:
Clin Infect Dis, Volume 62, Issue 8, p.972-979 (2016)Notes:
pii: civ1213